Page 474 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 474

CHaPTEr 32  Approach to the Evaluation of the Patient With Suspected Immunodeficiency                455



               KEY CONCEPTS                                       normally present in titers greater than 1 : 10; individuals with
            Diagnosis of Immune Deficiencies                      poor antibody production may have low or absent titers. Specific
                                                                  IgG antibody production can be measured following immuniza-
            Features of Congenital antibody Deficiencies          tion with protein antigens, such as toxoids derived from Tetanus
            •  Free of infections until 6–9 months of age, when maternal antibodies   and Diphtheria organisms, and polysaccharide antigens, such as
              that passed through the placenta to infant are below protective levels  those produced by pneumococci and Haemophilus influenzae.
            •  Severe infections with bacterial organisms, especially sinusitis, otitis   For pneumococcal immunization, there are two vaccines that
              media,  and pneumonias  caused by  encapsulated  bacteria,  such as   need to be differentiated. The conjugated vaccine containing 13
              Streptococcus pneumoniae                            pneumococcal serotypes (PREVNAR13,  Wyeth) is currently
                                                                  included in the universal schedule of immunizations for infants
            Features of Congenital T-Cell Immunodeficiency        and toddlers and induces a robust, T cell–dependent immune
            •  Onset of thrush, diarrhea, and failure to thrive in the first months of   response. The unconjugated 23-valent pneumococcal polysac-
              life
            •  Severe infections with opportunistic microorganisms, such as Pneu-  charide vaccine (Pneumovax, Merck) is available for immunization
              mocystis jiroveci, Candida albicans, adenovirus, cytomegalovirus (CMV),   to adults and children aged 2 years and older. The immune
              Epstein-Barr virus (EBV). “BCG-itis” in areas where Bacille Calmette-  response for this vaccine is considered less dependent on T cells
              Guérin (BCG) immunization is mandatory              and also less lasting than the conjugated vaccine. The pneumococ-
            •  Absolute and relative lymphopenia                  cal antigen challenge using the unconjugated vaccine is not
                                                                  recommended for children under 2 years of age because healthy
            Screening Tests for Suspected Immunodeficiency        children are not thought to reliably respond to the unconjugated
            •  Evaluation for neutropenia, lymphopenia, thrombocytopenia, and/or   pneumococcal antigen at this age. However, this view has been
              small platelets
            •  Immunoglobulin levels and specific antibodies to childhood   challenged by data showing that 1-year-old children produce
                                                                                                                  13,14
              immunizations                                       normal  antibody  responses  to  this unconjugated vaccine.
            •  Lateral chest radiography in infants for thymus shadow  Normal antibody responses are usually demonstrated with an
            •  Consider flow cytometry to quantify T cells, T-cell subsets, B cells,   over twofold rise in specific antibody levels within 2–3 weeks
              and natural killer (NK) cells (especially in infants)  for protein antigens and within 4–6 weeks for polysaccharide
            •  Measurement of CH50 activity                       antigens.  Patients with agammaglobulinemia are expected not
                                                                         15
            •  Test for oxidative burst in phagocytes
                                                                  to produce antibody responses, whereas others, such as those
                                                                  with IgG2 subclass deficiency and normal levels of total IgG,
                                                                  may only have difficulty with antibody production following
           IgE level measurement is  of significance for the  diagnosis of   immunization with polysaccharide antigens. Patients with selective
           HIES. Serum IgG subclasses levels can be determined. However,   IgA deficiency, alone or with transient hypogammaglobulinemia
           rather than using IgG subclass levels to screen for immunode-  of infancy, have normal specific IgG antibody production, by
           ficiency, they are best utilized when patients have clinical condi-  definition. The pneumococcal serotypes included in the current
           tions associated with specific antibody deficiencies but normal   conjugated antipneumococcal vaccine, serotypes 1, 3, 4, 5, 6A,
           total IgG levels. In some of these patients, IgG subclass deficiency,   6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, were estimated to be
           particularly IgG2 and IgG3 deficiencies, might be present. IgG2   responsible for approximately 90% of invasive pneumococcal
                                                                                                            16
           subclass deficiency has been linked with selective IgA deficiency   disease in children less than 5 years of age worldwide.  Previous
           and deficiency of antipolysaccharide antibodies. IgA subclass   immunization with the conjugate vaccine does not preclude use
           low levels, IgA1, IgA2, have not been associated with a specific   of the unconjugated pneumococcal polysaccharide vaccine. The
           immune defect, and there is no validity for measuring these.   23-valent polysaccharide vaccine provides the potential for
           The variation of normal ranges of human serum Igs with age   stimulation and measurement of a protective immune response
           is an important consideration in children, since IgA and IgG   to additional 11 serotypes (2, 8, 9N, 10A, 11A, 12F, 15B, 17F, 20,
           subclass levels may not reach normal adult reference ranges until   22F, 33F) not included in the conjugated vaccine. Testing for
           6 years of age. 1                                      antibodies against serotypes not included in the two vaccines
                                                                  and comparing the antibody titers in the pre- and postimmuniza-
           B-Cell Function: Specific Antibody Production          tion blood samples helps in the assessment of specific increase
           To properly assess B-cell function, specific antibody production   of particular antiserotype antibody titers as a response to the
           must be measured. Patients with normal Ig and Ig subclass levels   vaccine administration.
           might exhibit deficient antigen-dependent antibody responses.
           An initial screen of antibody production may involve the quan-  Evaluation of Cellular Immunity
           tification of isohemagglutinins. Isohemagglutinins occur in all   Cellular immune function had been historically screened with
           individuals except those with blood type AB; isohemagglutinins   the use of the delayed-type hypersensitivity (DTH) skin tests.
           are natural IgM antibodies to polysaccharide blood group antigens   DTH reactions occur 48–72 hours after antigen exposure, although
           A and/or B, which are not expressed in the red blood cells (RBCs)   antigens used to test DTH can occasionally produce immediate
           of the patient tested. Individuals form isohemagglutinins as a   hypersensitivity reactions. The clinical response and time of
           result of environmental exposure to ubiquitous antigens that   observation were to discriminate between immediate and delayed
           share epitopes with blood antigens. Children less than 1 year of   reactions. DTH reactions involve the production of local edema
           age do not reliably have measurable serum isohemagglutinins   and vasodilation as a result of inflammatory cytokines secreted
           because of the limited exposure to the environment. A patient   by antigen-specific T cells, followed by lymphocyte infiltration
           with blood type A should have anti-B IgM; patients with blood   and  maximal  induration  48  hours  after  antigen  intradermal
           type B should have anti-A IgM; and patients with blood type O   injection of an antigen. Generally, DTH skin tests are performed
           should have both anti-A and anti-B IgM. These antibodies are   using vaccine antigens or microbial agents to which the patient
   469   470   471   472   473   474   475   476   477   478   479